Skip to main content
. 2010 Dec 8;67(5):493–506. doi: 10.1007/s00228-010-0948-5

Fig. 2.

Fig. 2

Study flow sheet. The European Pharmacogenetic Opioid Study included 2,294 cancer patients of whom 461 were treated with oxycodone. Four hundred and forty-four used oral oxycodone, 439 were included in the analyses